Boyle Robert E 4
4 · PRUDENTIAL FINANCIAL INC · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
Prudential (PRU) SVP Robert Boyle Receives Award Shares
What Happened
Robert E. Boyle, Senior Vice President of Prudential Financial (PRU), received shares on February 9, 2026 through the conversion/grant of restricted and performance-based derivative awards. The filing shows Boyle acquired a total of 8,056 shares (1,020 from conversion, plus awards of 2,111 and 4,925 shares). The company withheld 411 shares to satisfy tax withholding obligations (411 × $102.20 = $42,004). The filing also reports 1,155 shares marked as disposed in connection with a conversion (reported at $0 in the filing). The Form 4 was filed on Feb 11, 2026 (timely).
Key Details
- Transaction date: 2026-02-09; Form 4 filed 2026-02-11 (timely).
- Acquisitions: 1,020 shares (conversion) + 2,111 RSU-type award + 4,925 performance-type award = 8,056 shares acquired; reported acquisition price $0 (derivative conversions/awards).
- Disposals/withholding: 411 shares withheld for taxes at $102.20 each = $42,004; 1,155 shares reported as disposed (reported value $0).
- Transaction codes: A = award/grant, M = exercise/conversion of derivative, F = shares withheld for taxes.
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Notable footnotes: performance-share amounts were determined based on Prudential’s ROE vs. peers and growth in adjusted book value per share for the 2023–2025 performance period; RSUs/performance shares convert 1:1 to common stock; RSU vesting is 1/3 per year beginning Feb 2027.
Context
These transactions reflect awards and the conversion of restricted/performance units rather than open-market purchases or sales. Withholding of shares to cover taxes (F) is a routine settlement step and does not necessarily signal a discretionary sale. Performance shares are contingent on company ROE and adjusted book-value growth, so final shares from such awards can depend on committee-determined performance results.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-09+1,020→ 3,830 total - Tax Payment
Common Stock
[F2]2026-02-09$102.20/sh−411$42,004→ 3,419 total - Award
2026 Restricted Stock Units
[F4][F5]2026-02-09+2,111→ 2,111 totalExercise: $0.00→ Common Stock (2,111 underlying) - Award
2026 Performance Shares
[F6][F7]2026-02-09+4,925→ 4,925 totalExercise: $0.00→ Common Stock (4,925 underlying) - Exercise/Conversion
2023 Performance Shares
[F1]2026-02-09−1,155→ 0 totalExercise: $0.00→ Common Stock (1,155 underlying)
- 935(indirect: By 401(k))
Common Stock
[F3]
Footnotes (7)
- [F1]The Compensation and Human Capital Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to the ROE performance of a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period.
- [F2]Represents shares withheld for the payment of taxes.
- [F3]Amount reported has been adjusted to include 21 shares of Issuer common stock acquired by the reporting person under The Prudential Employee Savings Plan between June 30, 2025, and December 31, 2025, based on a plan statement dated December 31, 2025. The acquisition of such shares was exempt from Section 16 pursuant to Rules 16b-3(c) and 16a-3(f)(1)(i)(B).
- [F4]The Restricted Stock Units convert to common stock on a 1 to 1 basis.
- [F5]The Restricted Stock Units will vest 1/3 per year beginning in February 2027.
- [F6]The performance shares convert to common stock on a 1 to 1 basis.
- [F7]Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation and Human Capital Committee in February 2029 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2026 through 2028 performance period.